Featured
Last news
Flash flood kills dozens in Morocco town
A flash flood in a Moroccan coastal town killed at least 37, local officials said Monday, as search and rescue operations continued.
Australia to toughen gun laws as it mourns deadly Bondi attack
Australia's leaders agreed Monday to toughen gun laws after attackers killed 15 people at a Jewish festival on Bondi Beach, the worst mass shooting in decades decried as antisemitic "terrorism" by authorities.
Hong Kong media mogul Jimmy Lai convicted of national security charges
Hong Kong pro-democracy media tycoon Jimmy Lai was found guilty on all three charges in his national security trial on Monday, convictions that rights groups denounced as the death knell for press freedoms in the Chinese financial hub.
Australia to toughen gun laws after deadly Bondi shootings
Australia's leaders agreed on Monday to tougher gun laws after the country's worst mass shooting in almost three decades saw a father and son open fire on a Jewish festival at Bondi Beach, killing 15 people including a child.
Jimmy Lai convicted of national security charges in Hong Kong
Hong Kong pro-democracy media tycoon Jimmy Lai was on Monday found guilty on two counts of foreign collusion and of seditious publication, in one of the Chinese city's highest-profile national security trials.
What we know about Australia's Bondi Beach attack
An attack by a father and son on a Jewish Hanukkah celebration at Sydney's Bondi Beach killed 15 people, plunging Australia into a day of mourning Monday.
Witnesses tell of courage, panic in wake of Bondi Beach shootings
A brave few dashed towards Australia's Bondi Beach as a mass shooting unfolded on Sunday night, wading through fleeing crowds to rescue children, treat the injured and confront the gunmen.
Chilean hard right victory stirs memories of dictatorship
When Chilean soldiers broke into her home and dragged her partner from bed on a spring night in 1986, Alicia Lira was 37 years old.
Healthcare Payer IT in 2026: Digital Prior Authorization, Enforceable Transparency, and Outcomes-Driven Platforms Spark a New Acquisition Race
CMS compliance deadlines and heightened cybersecurity expectations are accelerating payer interoperability and utilization management modernization while shifting vendor selection toward platforms that measurably shorten time-to-treatment, close gaps in care, and improve quality performance.
The Second Bloom of Nancy Strom
Scooter and Friends Take a Vacation by Nancy Strom
The Fresh Factory Announces US$3 Million Non-Brokered Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA for the fiscal year
Axpo Acquires American PowerNet and Partners with Power Synch
Axpo has acquired United States energy platform American PowerNet, it was announced today. Completed on December 10, 2025, the deal expands Axpo's footprint in the US retail energy market, serving end-use commercial and industrial (C&I) customers.
Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages
Company to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline
Design Driving Growth: Seven CPG Brands Recognized For Sales-Boosting Package Redesigns
The 2025 Designalytics Effectiveness Awards Spotlight Redesigns that Sparked Significant Sales Increases
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) - for which the company completed a meeting in October 2025 with the FDA in support of a possible expedited approval pathway
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, has no warnings or adverse events related to sexual dysfunction and no clinically significant weight gain compared to placebo
Vanderbilt Report: VisionWave Technologies, Inc Pursues European Defense Market Through £500,000 Evie Autonomous Partnership
BRISTOL, TN / ACCESS Newswire / December 15, 2025 / VisionWave Technologies, Inc (NASDAQ:VWAV) has entered into a £500,000 proof-of-concept program with Evie Autonomous, according to recent company disclosures. The agreement centers on integrating autonomous mobility systems into VisionWave's unmanned ground vehicle platforms, representing the company's most substantial commitment to the European defense market to date. The partnership leverages VisionWave's RF-driven perception technology to address capability gaps in GPS-denied and contested electromagnetic environments where traditional navigation systems face operational limitations.
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
KELOWNA, BC / ACCESS Newswire / December 15, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,661,600 shares of its common stock, par value $0.001 per share, at a purchase price of $1.315 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 2,661,600 shares of common stock. The warrants will have an exercise price of $1.19 per share, will be immediately exercisable and will expire five years from the date of the effectiveness of the resale registration statement registering the shares of common stock issuable upon exercise of the unregistered warrants. The closing of the offering is expected to occur on or about December 16, 2025, subject to the satisfaction of customary closing conditions.
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the European Union, subject to authorization by the European Commission
Amphastar Announces FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for teriparatide injection, USP 560 mcg/2.24mL (250 mcg/mL) single-patient-use prefilled pen. The FDA determined that Amphastar's teriparatide is bioequivalent and therapeutically equivalent to Eli Lilly's FORTEO®.
Lin Xiang Xiong Art Gallery Officially Opens
GEORGE TOWN, MY / ACCESS Newswire / December 15, 2025 / After more than two years of development since the signing of its main construction agreement in September 2023, the Lin Xiang Xiong Art Gallery officially opened its doors today. Penang Chief Minister YAB Tuan Chow Kon Yeow and former Prime Minister of France, His Excellency Jean-Pierre Raffarin, attended the unveiling ceremony, marking the arrival of a new international arts institution in Penang founded upon the ideals of art, humanity and peace.
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company) announced today the completion of its business combination with NeuroX Group SA (NeuroX), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases. The newly combined entity now operates under the name MindMaze Therapeutics Holding SA.
Father and son gunmen kill 15 at Jewish festival on Australia's Bondi Beach
A father-and-son team toting long-barelled guns shot and killed 15 people including a 10-year-old girl at Sydney's Bondi Beach, authorities said Monday, labelling it an antisemitic terrorist attack on a Jewish festival.
Hong Kong court to deliver verdicts on media mogul Jimmy Lai
Long-awaited verdicts in Hong Kong pro-democracy media tycoon Jimmy Lai's national security trial will be delivered on Monday, one of the city's most closely watched rulings since its return to Chinese rule in 1997.
World leaders express horror at Bondi beach shooting
World leaders voiced horror and revulsion at Sunday's mass shooting in which 11 people were killed at Sydney's Bondi Beach.
No contact with Iran Nobel winner since arrest: supporters
There has been no contact with Iranian Nobel peace prize winner Narges Mohammadi since her arrest at the end of last week, her supporters said Sunday, urging the Islamic republic to release the campaigner and dozens of others arrested alongside her.
World leaders express horror, revulsion at Bondi beach shooting
World leaders express their horror and revulsion at Sunday's mass shooting in which 11 people were killed at Sydney's iconic Bondi Beach.
Person of interest in custody after deadly shooting at US university
US authorities on Sunday detained a person of interest in a shooting at Brown University that left two people dead and nine others wounded, the latest in a long line of school attacks across the country.
Gunmen kill 11 at Jewish festival on Australia's Bondi Beach
Two gunmen opened fire at Sydney's Bondi Beach on Sunday, killing 11 people and wounding multiple others in a "terrorist incident" aimed at a gathering for the Jewish festival of Hanukkah in Australia.
Gunmen kill 11 during Jewish event at Sydney's Bondi Beach
Two gunmen opened fire at Sydney's Bondi Beach on Sunday, killing 11 people and wounding multiple others in a "terrorist incident" during a gathering for the Jewish festival of Hanukkah.
Shooting at Australia's Bondi Beach kills nine
Two suspected shooters opened fire at Sydney's iconic Bondi Beach on Sunday, killing nine people and wounding multiple others in an attack that spread panic, with bodies reported lying on the ground.